The office has appointed three directors and two advisers including Russell Cowburn, professor of experimental physics, and Cancer Research UK's Tony Hickson.

Robert Bahns has stepped down as technology partner at IP Group to become chief financial officer at one of the firm’s portfolio businesses, WaveOptics.

SoftBank Vision Fund investor Lydia Jett has been appointed to a partner position, having worked with portfolio companies such as Flipkart, Coupang and Tokopedia.

Elaine Jones, vice-president at pharmaceutical company Pfizer’s corporate venture capital unit, has shared highlights of her career with GCV ahead of her departure in April.

Alex Tepper has departed from a managing director position at General Electric's corporate VC unit to take a senior managing director role at startup studio Human Ventures.

The former head of Johnson & Johnson's JLabs@TMC incubator has been appointed director of Texas Medical Center's TMC Innovation Institute.

Busy Burr, a founding partner of Humana Health Ventures who featured on GCV’s 2017 and 2018 Powerlists, was named a director at Mr Cooper at the end of February.

Eric Steager, formerly managing director at Independence Blue Cross’ Strategic Innovation Portfolio unit, has taken a vice-president of corporate venture capital position at Anthem.

Katherine Ku has become a chief licensing adviser at law firm Wilson Sonsini Goodrich & Rosati after calling time on more than 27 years at Stanford’s OTL in June 2018.

Henry Choi has left Korea Investment Partners to lead global investment endeavours for Hana Ventures, the first corporate venture capital vehicle launched by a South Korea-based financial services firm.